The global plant tissue culture market size is expected to reach USD 791.3 Million by 2030 according to a new study by Polaris Market Research. The report “Plant Tissue Culture Market Share, Size, Trends, Industry Analysis Report, By End-Use (Agriculture, Research, Gardening & Decoration, Forestry & Botanical Garden, Others); By Crop Type; By Stage; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Rapid improvements in cell culture techniques and increasing demand for virus-free crops and many others will only further boost the market's development and provide significant potential prospects throughout the forecast period. One of the fascinating advancements in plant science is cell culture technology. Further, cell culture technologies, in conjunction with recombinant DNA technologies, are required to generate transgenic plants. However, techniques such as anther/pollen/ovule culture and cell culture can be used for plant breeding or to supplement conventional breeding. Isolated microspore cultivation has recently emerged as a breeding technique and laboratory for numerous genetic alterations.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/plant-tissue-culture-market/request-for-sample
Cell culture can be used to produce virus-free plants, which can help to reduce losses incurred by phytopathogens. Embryo culture has many possible applications, from overcoming root formation to facilitating inter-specific hybridization. Plant tissue culture and cell culture are important approaches for genetic storage, either by storing structured tissue at low temperatures or by freeze-drying cell or embryo culture.
Based on the crop type, the floriculture plants segment accounted for the leading share in the market. This is attributable to the rise of the cosmetics and personal care business and increased knowledge of the medicinal qualities of flowers, which is also contributing to market growth. Floral crops also provide decent pricing virtually all year, and the lock-in time from seeding to harvesting is much shorter than for other routine crops. Thus, floriculture is high in demand due to its benefits among various crop types.
Market players such as Rubi Bio LLC, Booms Pharm, Caisson Laboratories, Inc., Australis Capital Inc., Agriforest Bio-Technologies, Labland Biotech Private Limited, Alpha Laboratories, Phytoclone Inc., Merck KGaA, Thomas Scientific (The Carlyle Group), Phytotech Laboratories, Inc., and Tissue-Grown Corporation are some key players operating in the global market.
In March 2021, Australis Capital Inc. (AUSA) announced a joint venture relationship with 3 Rivers Biotech Inc., a premier agricultural techniques business, especially for commercial-scale micropropagation, also known as Plant Tissue Culture (PTC), for cannabis, hemp, and traditional crops.
Polaris Market Research has segmented the plant tissue culture market report based on crop type, stage, plant, end-use, and region:
Plant Tissue Culture, Crop Type Outlook (Revenue - USD Million, 2018 - 2030)
Plant Tissue Culture, Stage Outlook (Revenue - USD Million, 2018 - 2030)
Plant Tissue Culture, Plant Outlook (Revenue - USD Million, 2018 - 2030)
Plant Tissue Culture, End-Use Outlook (Revenue - USD Million, 2018 - 2030)
Plant Tissue Culture, Regional Outlook (Revenue - USD Million, 2018 - 2030)